ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1068

Classical Monocytes from African Ancestry Patients with Systemic Sclerosis Show Transcription and Energy Regulation Gene Expression Signatures

Paula Ramos1, Willian da Silveira 2, Jena Wirth 1, Nathan Wilson 1, Robert Wilson 1, Jin Hyun Nam 1, E. Starr Hazard 1, Jim Oates 3, Melissa Cunningham 1, Dongjun Chung 1 and Gary Hardiman 2, 1Medical University of South Carolina, Charleston, 2Queen’s University, Belfast, United Kingdom, 3Division of Rheumatology & Immunology/Medical University of South Carolina, Charleston, SC

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: African-Americans and monocytes, Gene Expression, Systemic sclerosis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 11, 2019

Title: Systemic Sclerosis & Related Disorders – Basic Science Poster

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic sclerosis (SSc) is a rare autoimmune disorder characterized by immune dysregulation, cutaneous and visceral fibrosis, and vasculopathy. It disproportionately affects African ancestry (AA) individuals who, despite the higher disease severity, are dramatically underrepresented in research. Monocytes show heightened activation in SSc, and in AA relative to European ancestry individuals. Monocytes are thus a good target tissue for elucidating disease mechanisms. In this study, we sought to characterize differential gene expression of classical monocytes in SSc patients and unaffected controls of African ancestry.

Methods: Classical monocytes (CD14++CD16-) were FACS-isolated from 17 female AA SSc cases and 18 female AA controls. All patients met the 2013 ACR/EULAR classification criteria for SSc, most (72%) presenting with diffuse cutaneous SSc. Total RNA was used to prepare RNA-Seq libraries using Illumina’s TruSeq RNA Exome kit. Upon sequencing on an Illumina HiSeq2500 instrument, data was analyzed by Rosalind, with a HyperScale architecture developed by OnRamp BioInformatics. Specifically, individual sample reads were aligned to the hg19 reference genome using STAR and quantified using HTseq. Differential expression analysis was implemented using DESeq2 and functional enrichment analysis was performed using Advaita iPathway Guide.

Results: A total of 743 genes showed differential expression (FDR P-value < 0.4). The top differentially expressed genes (P < E-04) include the collagen COL9A2 gene, the protein phosphatase PPP1R14B, the tubulin TUBB4B, the kinase-binding AKAP1, the ubiquitin ligase RNF146, the heparanase HPSE, the nuclear factor NF-Kappa-B activator TRAF3IP2, and the chromatin regulator SMARCA4. The SSc monocyte transcriptome showed an enrichment of genes in the AMPK signaling pathway, genes involved in chromatin organization, transcription factor binding, and glycogen storage diseases. The top upstream regulator is the MAPK11 kinase.

Conclusion: Unlike what has been reported in different peripheral blood subsets in EA patients, our results show a weaker upregulation of genes involved in immune and inflammatory processes in monocytes from AA patients. Instead, our study reveals an upregulation of genes involved in cellular processes associated with transcription and energy regulation in SSc patients, consistent with an increased metabolic rate of these myeloid cells in SSc. These results support the increasing awareness that metabolic reprogramming has important roles in mediating immune and vascular responses. Collectively, these results support the need to understand the regulatory architecture of SSc in different cell types and in individuals of different ancestries.


Disclosure: P. Ramos, None; W. da Silveira, None; J. Wirth, None; N. Wilson, None; R. Wilson, None; J. Nam, None; E. Hazard, None; J. Oates, None; M. Cunningham, None; D. Chung, None; G. Hardiman, None.

To cite this abstract in AMA style:

Ramos P, da Silveira W, Wirth J, Wilson N, Wilson R, Nam J, Hazard E, Oates J, Cunningham M, Chung D, Hardiman G. Classical Monocytes from African Ancestry Patients with Systemic Sclerosis Show Transcription and Energy Regulation Gene Expression Signatures [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/classical-monocytes-from-african-ancestry-patients-with-systemic-sclerosis-show-transcription-and-energy-regulation-gene-expression-signatures/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/classical-monocytes-from-african-ancestry-patients-with-systemic-sclerosis-show-transcription-and-energy-regulation-gene-expression-signatures/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology